Cole, Katherine Marie
McGee, Sharon
Clemons, Mark
Liu, Michelle
MacDonald, Fiona
Vandermeer, Lisa
Ng, Terry L.
Pond, Gregory
Emam, Khaled El
Article History
Received: 26 January 2024
Accepted: 24 April 2024
First Online: 19 May 2024
Declarations
:
: KEE is co-founder and has financial interests in Replica Analytics Ltd., a spin-off from his research lab that develops synthetic data generation software. TLN served on an advisory board for Novartis and Knight Therapeutics, served as an educational speaker for Eli Lilly and Takeda Oncology, and received a prior research grant from Takeda Oncology. GP has received consulting fees from Merck, Astra-Zeneca, and Profound Medical, has received honorarium for DSMB membership from Takeda, and has a family member who is an employee of Roche Canada and who owns stock in Roche Ltd. KC, SM, MC, ML, FM, and LV declare no conflicts of interest.
: This study was performed per the principles of the Declaration of Helsinki. The reported studies were approved by the Ottawa Health Sciences Research Ethics Board protocols OHSN REB #20210727-01H and OHSN REB #20210827-01H. Informed consent was obtained from all included participants.
: Patients were involved in the question development/piloting of earlier hot flashes surveys, and some of these questions were utilized in the current project.